FDAnews Announces — Electronic Informed Consent for Biobanks: Transitioning to a 21st-Century System Webinar, Jan. 14, 2016

Share Article

Many biobanks are still using a cumbersome paper-based system for documenting consent. Join Susan G. Brink, DrPH — executive vice president of e-consent products and services at Enforme Interactive, Inc — for a 90-minute session discussing the implementation of e-Consent for biobanks.

Electronic Informed Consent for Biobanks:
Transitioning to a 21st-Century System
Jan. 14, 2016 — 1:30 p.m. – 3:00 p.m. EST
http://www.fdanews.com/electronicinformedconsentbiobanks

Many biobanks are still using a cumbersome paper-based system for documenting consent.

Join Susan G. Brink, DrPH — executive vice president of e-consent products and services at Enforme Interactive, Inc — for a 90-minute session discussing the implementation of e-Consent for biobanks. She will:

  • Provide guidelines for a flexible approach to collect and maintain patient consents.
  • Give examples of how an e-consent platform can address biobank issues including general consent for all uses, specific consent, specimen withdrawal by patient, specimen matching to consent and patient notification while maintaining confidentiality of patient information.
  • Provide a workflow analysis for a specimen management system with real time access to consent.

Register today and discover how moving to an e-Consent system can simplify everything.

Who Will Benefit:

  • Auditors
  • Clinical project specialists
  • Clinical research associates
  • Clinical operations
  • Compliance officers
  • Consultants/service providers
  • Engineering and design controls teams
  • Executive management
  • General/corporate counsel
  • R&D staff
  • Regulatory/legislative affairs professionals
  • Study monitors
  • Study research coordinators
  • Study sponsors
  • Biobank managers
  • Biobank managing director
  • Biosample manager
  • Biorepository director

Meet the Instructor:
Susan G. Brink, DrPH
Exec. Vice President, e-consent Products and Services, Enforme Interactive, Inc.

Susan Brink has over 25 years of experience in research and development in the area of public health interventions, patient and consumer health information and patient decision-making. Dr. Brink has been involved in the creation of e-consent products for patients and clinical staff since 2003. As the principal investigator on an NIH Clinical Trials Office SBIR grant to develop an electronic approach to informed consent, she provided the initial vision, guidance and research for the development of SecureConsent.

Webinar Details:
Electronic Informed Consent for Biobanks:
Transitioning to a 21st-Century System
Jan. 14, 2016 — 1:30 p.m. – 3:00 p.m. EST
http://www.fdanews.com/electronicinformedconsentbiobanks

Tuition:
$287 per site

Easy Ways to Register:
Online: http://www.fdanews.com/electronicinformedconsentbiobanks
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website